Back
Cathay General Bancorp Vs. Royalty Pharma PLC Industry Stock Comparison
Sell
50
CATY
Cathay General Bancorp
Last Price:
$42.65
Seasonality Move:
0.85%
Sell
28
RPRX
Royalty Pharma PLC
Last Price:
$31.38
Seasonality Move:
-2.74%
Sell
50
Cathay General Bancorp (CATY)
is a Sell
Is Cathay General Bancorp a Buy, Sell or Hold?
-
The current Cathay General Bancorp [CATY] share price is $42.63. The Score for CATY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
CATY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy, Sell or Hold?
-
The current Royalty Pharma PLC [RPRX] share price is $31.37. The Score for RPRX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
RPRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CATY Stock Price Chart
What is Cathay General Bancorp's stock price today?
-
The Cathay General Bancorp share price today is $42.63Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATY is experiencing selling pressure, which indicates risk of future bearish movement.
RPRX Stock Price Chart
What is Royalty Pharma PLC's stock price today?
-
The Royalty Pharma PLC share price today is $31.37Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing slight selling pressure.
CATY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.76 | Sell |
Relative Strength Index (14 RSI): | 37.36 | Sell |
Chaikin Money Flow: | -125877 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.99 - 45.91) | Sell |
Bollinger Bands (100): | (44.91 - 50.65) | Sell |
RPRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 35.44 | Sell |
Chaikin Money Flow: | -282065 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.41 - 33.81) | Sell |
Bollinger Bands (100): | (26.01 - 32.63) | Buy |
CATY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.55 | Sell |
20-day SMA: | 43.99 | Sell |
50-day SMA: | 45.87 | Sell |
200-day SMA: | 44.6 | Sell |
8-day EMA: | 43.45 | Sell |
20-day EMA: | 44.07 | Sell |
50-day EMA: | 45.39 | Sell |
200-day EMA: | 44.67 | Sell |
RPRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.84 | Sell |
20-day SMA: | 32.99 | Sell |
50-day SMA: | 32.42 | Sell |
200-day SMA: | 28.45 | Buy |
8-day EMA: | 32.44 | Sell |
20-day EMA: | 32.75 | Sell |
50-day EMA: | 31.89 | Sell |
200-day EMA: | 29.45 | Buy |
Cathay General Bancorp Earnings Growth & CATY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.02 per share, an increase this year of $0.20 per share, and an increase next year of $0.53 per share.
Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.18 per share, an increase this year of $0.62 per share, and an increase next year of $0.31 per share.
Cathay General Bancorp Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Royalty Pharma PLC Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |